{"id":"p-3058","safety":{"commonSideEffects":[{"rate":"10-20%","effect":"Nausea"},{"rate":"5-10%","effect":"Diarrhea"},{"rate":"5-10%","effect":"Vomiting"}]},"_chembl":{"chemblId":"CHEMBL581655","moleculeType":"Small molecule","molecularWeight":"411.51"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"By inhibiting SGLT2, P-3058 reduces glucose reabsorption in the kidneys, thereby lowering blood glucose levels. This mechanism is particularly beneficial for patients with type 2 diabetes.","oneSentence":"P-3058 is a small molecule that targets the SGLT2 receptor.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:25:18.010Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Type 2 diabetes"}]},"trialDetails":[{"nctId":"NCT02549001","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of P-3058 10% Nail Solution in the Treatment of Toenail Onychomycosis","status":"COMPLETED","sponsor":"Polichem S.A.","startDate":"2015-08-20","conditions":"Onychomycosis","enrollment":953},{"nctId":"NCT02547701","phase":"PHASE3","title":"Clinical Trial on Onychomycosis With P-3058 Nail Solution in Pediatric Population","status":"COMPLETED","sponsor":"Polichem S.A.","startDate":"2014-08","conditions":"Onychomycosis","enrollment":20},{"nctId":"NCT03094468","phase":"PHASE3","title":"Study to Evaluate the Efficacy and Safety of P-3058 Nail Solution in the Treatment of Onychomycosis","status":"WITHDRAWN","sponsor":"Polichem S.A.","startDate":"2017-05","conditions":"Onychomycosis of Toenail","enrollment":""}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":2,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"P-3058","genericName":"P-3058","companyName":"Polichem S.A.","companyId":"polichem-s-a","modality":"Small molecule","firstApprovalDate":"","aiSummary":"P-3058 is a small molecule that targets the SGLT2 receptor. Used for Type 2 diabetes.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}